17 alpha-hydroxylase deficiency: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
{{SK}} 17 alpha-hydroxylase deficiency; 17 alpha-hydroxylase deficiency; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency | {{SK}} 17 alpha-hydroxylase deficiency; 17 alpha-hydroxylase deficiency; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency | ||
==[[ | ==[[17 alpha-hydroxylase deficiency overview|Overview]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency historical perspective|Historical Perspective]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency causes|Causes]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency differential diagnosis|Differentiating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency From Other Diseases]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency risk factors|Risk Factors]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency screening|Screening]]== | ||
==[[ | ==[[17 alpha-hydroxylase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[17 alpha-hydroxylase deficiency history and symptoms|History and Symptoms]] | [[17 alpha-hydroxylase deficiency physical examination|Physical Examination]] | [[17 alpha-hydroxylase deficiency laboratory findings|Laboratory Findings]] | [[17 alpha-hydroxylase deficiency CT|CT]] | [[17 alpha-hydroxylase deficiency MRI|MRI]] | [[17 alpha-hydroxylase deficiency ultrasound|Ultrasound]] | [[17 alpha-hydroxylase deficiency other imaging findings|Other Imaging Findings]] | [[17 alpha-hydroxylase deficiency other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[17 alpha-hydroxylase deficiency medical therapy|Medical Therapy]] | [[17 alpha-hydroxylase deficiency surgery|Surgery]] | [[17 alpha-hydroxylase deficiency prevention|Prevention]] | [[17 alpha-hydroxylase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[17 alpha-hydroxylase deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 19:02, 3 August 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: 17 alpha-hydroxylase deficiency; 17 alpha-hydroxylase deficiency; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies